Pregnancy Rate After Unilateral Tubal Disconnection
Launched by TANTA UNIVERSITY · May 12, 2020
Trial Information
Current as of May 03, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective a specific surgery, called unilateral tubal disconnection, is for helping women become pregnant. This procedure involves disconnecting one fallopian tube that is affected by a condition known as hydrosalpinx, which can impact fertility. The goal is to see if this surgery can improve pregnancy rates for women who are struggling to conceive.
Women who might be eligible to participate in this trial are those who have been diagnosed with infertility, either as a primary issue (they have never been able to get pregnant) or as a secondary issue (they have previously been pregnant but cannot conceive again) due to hydrosalpinx. However, women with other causes of infertility will not be included in this study. If you choose to participate, you can expect to undergo the surgical procedure, and the trial will monitor your pregnancy outcomes afterward. This study is currently recruiting participants, and it's an opportunity to contribute to research that could help many women in similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • infertile women either primary or secondary Hydrosalpinx
- Exclusion Criteria:
- • other factors of infertility
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Gharbia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials